Skip to main content
DaehanPharmaceutical logo

DaehanPharmaceutical — Investor Relations & Filings

Ticker · 023910 ISIN · KR7023910003 KO Manufacturing
Open in API
Filings indexed 302 across all filing types
Latest filing 2025-12-30 Director's Dealing
Country KR South Korea
Listing KO 023910

About DaehanPharmaceutical

https://www.dhnp.co.kr/

Daehan Nupharm is a pharmaceutical company engaged in the research, development, and manufacturing of a diverse portfolio of healthcare products. The company's business is structured around four core areas: human pharmaceuticals, offering a range of therapeutic treatments; animal health products for both companion and livestock animals; advanced bio-pharmaceuticals, with a focus on next-generation technologies like cell therapy; and health functional foods. Established initially in the animal health sector, the company leverages its dedicated Central and Bio Research Institutes to drive innovation and develop solutions for global markets. The R&D efforts concentrate on strengthening technological capabilities and advancing new treatment modalities.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Cho Young-ki) of Daehan Pharmaceutical Co., Ltd. It details the sale of shares by an insider. This corresponds to the 'Director's Dealing' category, which covers personal share transactions by company directors and executives.
2025-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details share transactions (장내매수 - on-market purchase) by a director/major shareholder (Lee Yoon-woo) of Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2025-12-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the personal share transactions (disposals) made by a director (Cho Young-ki) of Daehan Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a Director's Dealing (DIRS) report, as it tracks insider trading activity.
2025-12-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It contains detailed information about the ownership and changes in ownership of securities by an executive named 이윤우, including dates, share counts, and percentages. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange. This type of filing corresponds to notifications about insider shareholdings or changes in significant share ownership levels. According to the filing definitions, this matches the category 'Major Shareholding Notification' (Code: MRQ). The document length is 2574 characters, which is consistent with a detailed ownership notification rather than a full report or announcement. Therefore, the correct classification is MRQ with high confidence.
2025-11-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Certain Securities by Executives and Major Shareholders.' It includes detailed information about the ownership of securities by an executive or major shareholder, including dates, share counts, ownership percentages, and transaction details. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange, indicating it is a formal ownership disclosure. This matches the definition of a Major Shareholding Notification (MRQ), which involves notification of changes in significant share ownership levels. The document length is 2521 characters, which is consistent with a detailed ownership report rather than a brief announcement or a full financial report. Therefore, the correct classification is MRQ with high confidence.
2025-10-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report on Ownership Status of Specific Securities by Executives and Major Shareholders.' It includes detailed information about the ownership of securities by an executive named 이윤우, including the number of shares owned, changes in ownership, and related dates. The document is addressed to regulatory bodies such as the Securities and Futures Commission and the Korea Exchange. This type of filing corresponds to a notification of insider share transactions or holdings by directors and executives. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 2471 characters, which is consistent with a detailed insider transaction report rather than a full financial report or announcement.
2025-10-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.